Longitudinal changes in iron homeostasis in human experimental and clinical malariaResearch in context
Stephen D. Woolley,
Matthew J. Grigg,
Louise Marquart,
Jeremy S.E. Gower,
Kim Piera,
Arya Sheela Nair,
Fiona M. Amante,
Giri S. Rajahram,
Timothy William,
David M. Frazer,
Stephan Chalon,
James S. McCarthy,
Nicholas M. Anstey,
Bridget E. Barber
Affiliations
Stephen D. Woolley
Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Academic Department of Military Medicine, Royal Centre for Defence Medicine, Birmingham, United Kingdom
Matthew J. Grigg
Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia; Infectious Diseases Society Kota Kinabalu Sabah–Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia
Louise Marquart
Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia; School of Public Health, University of Queensland, Brisbane, Australia
Jeremy S.E. Gower
Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Kim Piera
Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia
Arya Sheela Nair
Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Fiona M. Amante
Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Giri S. Rajahram
Infectious Diseases Society Kota Kinabalu Sabah–Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia; Department of Medicine, Queen Elizabeth II Hospital, Kota Kinabalu, Malaysia; Clinical Research Centre, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia
Timothy William
Infectious Diseases Society Kota Kinabalu Sabah–Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia; Clinical Research Centre, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia; Subang Jaya Medical Centre, Subang Jaya, Malaysia
David M. Frazer
Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Stephan Chalon
Medicines for Malaria Venture, Geneva, Switzerland
James S. McCarthy
Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia; Victorian Infectious Diseases Institute, Peter Doherty Institute, University of Melbourne, Melbourne, Australia
Nicholas M. Anstey
Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia; Infectious Diseases Society Kota Kinabalu Sabah–Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia
Bridget E. Barber
Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia; Infectious Diseases Society Kota Kinabalu Sabah–Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia; Infectious Diseases Department, Royal Brisbane and Women's Hospital, Brisbane, Australia; Corresponding author. QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, QLD, 4006, Australia.
Summary: Background: The interaction between iron status and malaria is incompletely understood. We evaluated longitudinal changes in iron homeostasis in volunteers enrolled in malaria volunteer infection studies (VIS) and in Malaysian patients with falciparum and vivax malaria. Methods: We retrieved data and samples from 55 participants (19 female) enrolled in malaria VIS, and 171 patients (45 female) with malaria and 30 healthy controls (13 female) enrolled in clinical studies in Malaysia. Ferritin, hepcidin, erythropoietin, and soluble transferrin receptor (sTfR) were measured by ELISA. Findings: In the VIS, participants’ parasitaemia was correlated with baseline mean corpuscular volume (MCV), but not iron status (ferritin, hepcidin or sTfR). Ferritin, hepcidin and sTfR all increased during the VIS. Ferritin and hepcidin normalised by day 28, while sTfR remained elevated. In VIS participants, baseline ferritin was associated with post-treatment increases in liver transaminase levels. In Malaysian patients with malaria, hepcidin and ferritin were elevated on admission compared to healthy controls, while sTfR increased following admission. By day 28, hepcidin had normalised; however, ferritin and sTfR both remained elevated. Interpretation: Our findings demonstrate that parasitaemia is associated with an individual's MCV rather than iron status. The persistent elevation in sTfR 4 weeks post-infection in both malaria VIS and clinical malaria may reflect a causal link between malaria and iron deficiency. Funding: National Health and Medical Research Council (Program Grant 1037304, Project Grants 1045156 and 1156809; Investigator Grants 2016792 to BEB, 2016396 to JCM, 2017436 to MJG); US National Institute of Health (R01-AI116472-03); Malaysian Ministry of Health (BP00500420).